Vireo Growth (VREOF) Amortization of Deferred Charges (2021 - 2026)

Vireo Growth (VREOF) reported Amortization of Deferred Charges of $1.1 million for Q1 2026, down 8.33% on a YoY basis from $1.2 million in Q1 2025, and up 31.81% sequentially from $834529.0 in Q4 2025.

Vireo Growth (VREOF) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 6 years of Amortization of Deferred Charges data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortization of Deferred Charges fell 8.33% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 4.26% YoY), and the FY2025 full-year result was $3.9 million, down 18.47% from the prior year.
  • Amortization of Deferred Charges rose to $1.1 million in Q1 2026, from $834529.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.0 million in Q1 2024 to a low of $590240.0 in Q3 2025.
  • A 5-year average of $1.3 million and a median of $1.2 million in 2025 frame the typical range for Amortization of Deferred Charges.
  • Across the five-year window, Amortization of Deferred Charges surged 63.05% in 2022 and sank 52.88% in 2024, its largest moves.
  • Tracing VREOF's Amortization of Deferred Charges over 5 years: stood at $1.5 million in 2022, then jumped by 30.12% to $2.0 million in 2023, then sank by 49.55% to $987925.0 in 2024, then declined by 15.53% to $834529.0 in 2025, then surged by 31.81% to $1.1 million in 2026.
  • Business Quant data shows VREOF's Amortization of Deferred Charges at $1.1 million in Q1 2026, $834529.0 in Q4 2025, and $590240.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 834,529.00
Dec 31, 2025 834,529.00
Sep 30, 2025 590,240.00
Sep 30, 2025 590,240.00
Jun 30, 2025 1.28 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.20 Mn
Mar 31, 2025 1.20 Mn
Dec 31, 2024 987,925.00
Dec 31, 2024 987,925.00
Sep 30, 2024 889,838.00
Sep 30, 2024 889,838.00
Jun 30, 2024 900,366.00
Jun 30, 2024 900,366.00
Mar 31, 2024 2.02 Mn
Mar 31, 2024 2.02 Mn
Dec 31, 2023 1.96 Mn
Dec 31, 2023 1.96 Mn